Synthesis, transportability and hypoxiaselective binding of 1-beta-D-(5-Deoxy-5-fluororibofuranosyl)-2-nitroimidazole (beta-5-FAZR), a configurational isomer of the clinical hypoxia marker, FAZA.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques

Volumn 10, Issue 2, 2007, Pages 237-245

  Emamia, Saeed ^a   Kumar, Piyush ^a   Yang, Jennifer ^a   Kresolic, Zbigniew ^a   Paproskic, Robert ^a   Cass, Carol ^a   McEwan, Alexander Jb ^a   Wiebea, Leonard I ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CIF NUCLEOSIDE TRANSPORTER; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; NITROIMIDAZOLE DERIVATIVE; RADIOSENSITIZING AGENT; SLC29A1 PROTEIN, HUMAN; UNCLASSIFIED DRUG; URIDINE;

ARTICLE; CELL HYPOXIA; CELL STRAIN HCT116; COLORECTAL TUMOR; GAMMA RADIATION; HUMAN; ISOMERISM; METABOLISM; SYNTHESIS;

CELL HYPOXIA; COLORECTAL NEOPLASMS; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2; GAMMA RAYS; HCT116 CELLS; HUMANS; ISOMERISM; MEMBRANE TRANSPORT PROTEINS; NITROIMIDAZOLES; RADIATION-SENSITIZING AGENTS; URIDINE;

EID: 34848874105     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Article

References (0)